BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

274 related articles for article (PubMed ID: 15142613)

  • 1. Lamotrigine: a depression mood stabiliser.
    Herman E
    Eur Neuropsychopharmacol; 2004 May; 14 Suppl 2():S89-93. PubMed ID: 15142613
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Depression mood stabilisation: novel concepts and clinical management.
    Calabrese JR
    Eur Neuropsychopharmacol; 2004 May; 14 Suppl 2():S100-7. PubMed ID: 15142615
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Spotlight on lamotrigine in bipolar disorder.
    Goldsmith DR; Wagstaff AJ; Ibbotson T; Perry CM
    CNS Drugs; 2004; 18(1):63-7. PubMed ID: 14731061
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Role of lamotrigine in the management of treatment-resistant bipolar II depression: a chart review.
    Sharma V; Khan M; Corpse C
    J Affect Disord; 2008 Nov; 111(1):100-5. PubMed ID: 18314200
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mood stabilization and destabilization during acute and continuation phase treatment for bipolar I disorder with lamotrigine or placebo.
    Goldberg JF; Calabrese JR; Saville BR; Frye MA; Ketter TA; Suppes T; Post RM; Goodwin FK
    J Clin Psychiatry; 2009 Sep; 70(9):1273-80. PubMed ID: 19689918
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A placebo-controlled 18-month trial of lamotrigine and lithium maintenance treatment in recently manic or hypomanic patients with bipolar I disorder.
    Bowden CL; Calabrese JR; Sachs G; Yatham LN; Asghar SA; Hompland M; Montgomery P; Earl N; Smoot TM; DeVeaugh-Geiss J;
    Arch Gen Psychiatry; 2003 Apr; 60(4):392-400. PubMed ID: 12695317
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Early antidepressant effect of memantine during augmentation of lamotrigine inadequate response in bipolar depression: a double-blind, randomized, placebo-controlled trial.
    Anand A; Gunn AD; Barkay G; Karne HS; Nurnberger JI; Mathew SJ; Ghosh S
    Bipolar Disord; 2012 Feb; 14(1):64-70. PubMed ID: 22329473
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Adjunctive lamotrigine therapy for patients with bipolar II depression partially responsive to mood stabilizers.
    Chang JS; Moon E; Cha B; Ha K
    Prog Neuropsychopharmacol Biol Psychiatry; 2010 Oct; 34(7):1322-6. PubMed ID: 20673782
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A factor analytic study in bipolar depression, and response to lamotrigine.
    Mitchell PB; Hadzi-Pavlovic D; Evoniuk G; Calabrese JR; Bowden CL
    CNS Spectr; 2013 Aug; 18(4):214-24. PubMed ID: 23702258
    [TBL] [Abstract][Full Text] [Related]  

  • 10. PHARMAC and treatment of bipolar depression--the limits of utilitarianism.
    Ellis P; Mulder R; Porter R
    N Z Med J; 2006 Mar; 119(1231):U1924. PubMed ID: 16582981
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Recurrence in bipolar I disorder: a post hoc analysis excluding relapses in two double-blind maintenance studies.
    Calabrese JR; Goldberg JF; Ketter TA; Suppes T; Frye M; White R; DeVeaugh-Geiss A; Thompson TR
    Biol Psychiatry; 2006 Jun; 59(11):1061-4. PubMed ID: 16769295
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Stabilization of mood from below versus above baseline in bipolar disorder: a new nomenclature.
    Ketter TA; Calabrese JR
    J Clin Psychiatry; 2002 Feb; 63(2):146-51. PubMed ID: 11874216
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Treatment-resistant bipolar depression: a STEP-BD equipoise randomized effectiveness trial of antidepressant augmentation with lamotrigine, inositol, or risperidone.
    Nierenberg AA; Ostacher MJ; Calabrese JR; Ketter TA; Marangell LB; Miklowitz DJ; Miyahara S; Bauer MS; Thase ME; Wisniewski SR; Sachs GS
    Am J Psychiatry; 2006 Feb; 163(2):210-6. PubMed ID: 16449473
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Lamotrigine for bipolar disorder: translating research into clinical practice.
    Fung J; Mok H; Yatham LN
    Expert Rev Neurother; 2004 May; 4(3):363-70. PubMed ID: 15853534
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Lamotrigine in the acute treatment of bipolar depression: results of five double-blind, placebo-controlled clinical trials.
    Calabrese JR; Huffman RF; White RL; Edwards S; Thompson TR; Ascher JA; Monaghan ET; Leadbetter RA
    Bipolar Disord; 2008 Mar; 10(2):323-33. PubMed ID: 18271912
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The cost-effectiveness of lamotrigine in the maintenance treatment of adults with bipolar I disorder.
    Calvert NW; Burch SP; Fu AZ; Reeves P; Thompson TR
    J Manag Care Pharm; 2006 May; 12(4):322-30. PubMed ID: 16792438
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinical studies on the use of lamotrigine in bipolar disorder.
    Calabrese JR; Rapport DJ; Shelton MD; Kujawa M; Kimmel SE
    Neuropsychobiology; 1998 Oct; 38(3):185-91. PubMed ID: 9778607
    [TBL] [Abstract][Full Text] [Related]  

  • 18. New approaches in managing bipolar depression.
    Keck PE; McElroy SL
    J Clin Psychiatry; 2003; 64 Suppl 1():13-8. PubMed ID: 12625800
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Lamotrigine (Lamictal IR) for the treatment of bipolar disorder.
    Bowden CL; Singh V
    Expert Opin Pharmacother; 2012 Dec; 13(17):2565-71. PubMed ID: 23140205
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mood state at study entry as predictor of the polarity of relapse in bipolar disorder.
    Calabrese JR; Vieta E; El-Mallakh R; Findling RL; Youngstrom EA; Elhaj O; Gajwani P; Pies R
    Biol Psychiatry; 2004 Dec; 56(12):957-63. PubMed ID: 15601606
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.